Cytokine production by non-stimulated peripheral blood NK cells and lymphocytes in early-onset severe pre-eclampsia without HELLP

Journal of Reproductive Immunology

Volumn 97, Issue 2, 2013, Pages 223-231

  Bueno Sanchez J C ^a   Agudelo Jaramillo, B ^a,b   Escobar Aguilerae, L F ^c   Lopera, A ^a   Cadavid Jaramillo, A P ^a   Chaouat, G ^d   Maldonado Estrada, J G ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b HOSPITAL UNIVERSITARIO SAN VICENTE FUNDACIÓN   (Colombia)

^c Hospital General de Medellin Luz Castro de Gutierrez ESE   (Colombia)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Early onset severe preeclampsia; Natural killer cells; Systemic inflammatory response syndrome

Indexed keywords

GAMMA INTERFERON; HLA E ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELLP SYNDROME; LYMPHOCYTE; NATURAL KILLER CELL; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANTIGENS, CD; CYTOKINES; FEMALE; HELLP SYNDROME; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-G ANTIGENS; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; YOUNG ADULT;

EID: 84875396379     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.11.007     Document Type: Article

References (42)

1. Anon. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obst. Gynecol. 2002, 99(January (33)):159-167.
2. Borzychowski A.M., Croy B.A., Chan W.L., Redman C.W., Sargent I.L. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur. J. Immunol. 2005, 35:3054-3063.
3. Borzychowski A.M., Sargent I.L., Redman C.W. Inflammation and pre-eclampsia. Semin. Fetal. Neonatal Med. 2006, 11:309-316.
4. Chaouat G., Petitbarat M., Bulla R., Dubanchet S., Valdivia K., et al. Early regulators in abortion and implications for a preeclampsia model. J. Reprod. Immunol. 2009, 82:131-140.
5. Colonna M., Jonjic S., Watzl C. Natural killer cells: fighting viruses and much more. Nat. Immunol. 2011, 12:107-110.
6. Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.P., et al. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007, 109:2806-2814.
7. Darmochwal-Kolarz D., Rolinski J., Leszczynska-Goarzelak B., Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am. J. Reprod. Immunol. 2002, 48:381-386.
8. Germain S.J., Sacks G.P., Sooranna S.R., Sargent I.L., Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 2007, 178:5949-5956.
9. Hackmon R., Koifman A., Hyodo H., Glickman H., Sheiner E., et al. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am. J. Obstet. Gynecol. 2007, 197:255.e1-255.e5.
10. Henao D.E., Arias L.F., Mathieson P.W., Ni L., Welsh G.I., et al. Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron. Exp. Nephrol. 2008, 110:73-81.
11. Higai K., Imaizumi Y., Suzuki C., Azuma Y., Matsumoto K. NKG2D and CD94 bind to heparin and sulfate-containing polysaccharides. Biochem. Biophys. Res. Commun. 2009, 386:709-714.
12. Higai K., Suzuki C., Imaizumi Y., Xin X., Azuma Y., et al. Binding affinities of NKG2D and CD94 to sialyl Lewis X-expressing N-glycans and heparin. Biol. Pharmaceut. Bull. 2011, 34:8-12.
13. Higuma-Myojo S., Sasaki Y., Miyazaki S., Sakai M., Siozaki A., et al. Cytokine profile of natural killer cells in early human pregnancy. Am. J. Reprod. Immunol. 2005, 54:21-29.
14. Hill J.A., Hsia S., Doran D.M., Bryans C.I. Natural killer cell activity and antibody dependent cell-mediated cytotoxicity in preeclampsia. J. Reprod. Immunol. 1986, 9:205-212.
15. Jacobs R., Hintzen G., Kemper A., Beul K., Kempf S., et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol. 2010, 31:3121-3126.
16. Kanai T., Fujii T., Kozuma S., Miki A., Yamashita T., et al. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1. J. Reprod. Immunol. 2003, 60:85-96.
17. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998, 8:693-701.
18. Leik C.E., Walsh S.W. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 2004, 44:72-77.
19. McCracken S.A., Gallery E., Morris J.M. Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success. J. Immunol. 2004, 172:4583-4591.
20. Mendes R., Bromelow K.V., Westby M., Galea-Lauri J., Smith I.E., et al. Flow cytometric visualisation of cytokine production by CD3- CD56+ NK cells and CD3+ CD56+ NK-T cells in whole blood. Cytometry 2000, 39:72-78.
21. Mignini L.E., Villar J., Khan K.S. Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am. J. Obst. Gynecol. 2006, 194:317-321.
22. Morandi B., Bougras G., Muller W.A., Ferlazzo G., Münz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFNgamma secretion. Eur. J. Immunol. 2006, 36:2394-2400.
23. Naume B., Nonstad U., Steinkjer B., Funderud S., Smeland E., et al. Immunomagnetic isolation of NK and LAK cells. J. Immunol. Methods 1991, 136:1-9.
24. Piriou L., Chilmonczyk S., Genetet N., Albina E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 2000, 41:289-297.
25. Riederer I., Sievert W., Eissner G., Molls M., Multhoff G. Irradiation-induced up-regulation of HLA-E on macrovascular endothelial cells confers protection against killing by activated natural killer cells. PLoS ONE 2010, 5:15339.
26. Robillard P.-Y., Chaouat G., Le Bouteiller P., Fournier T., Barau G., et al. Débats actuels sur l'immunologie de la prééclampsie. Comptes rendus du sixième colloque international de La Réunion (décembre 2008). Gynécol. Obstét. Fert. 2009, 37:570-578.
27. Rolfo A., Many A., Racano A., Tal R., Tagliaferro A., et al. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS ONE 2010, 5(10):e13288. 10.1371/journal.pone.0013288.
28. Sáez-Borderías A., Romo N., Magri G., Gumá M., Angulo A., et al. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function. J. Immunol. 2009, 182:829-836.
29. Saito S., Sakai M., Sasaki Y., Nakashima A., Shiozaki A. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol. 2007, 76:30-39.
30. Saito S., Nakashima A., Myojo-Higuma S., Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. 2008, 77:14-22.
31. Sibai B.M. Imitators of severe pre-eclampsia. Semin. Perinatol. 2009, 33:196-205.
32. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365(9461):785-799.
33. Siklós P., Németh-Csóka A., Bartalits L., Ungár L., Hercz P., et al. Decreased killer cell activity in preeclampsia. Gynecol. Obstet. Invest. 1987, 23:84-88.
34. Sivori S., Parolini S., Marcenaro E., Millo R., Bottino C., et al. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell. Hum. Immunol. 2000, 61:1055-1058.
35. Steinborn A., Varkonyi T., Scharf A., Bahlmann F., Klee A., et al. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am. J. Reprod. Immunol. 2007, 57:277-286.
36. Turner J.A. Diagnosis and management of pre-eclampsia: an update. Int. J. Womens Health 2010, 2:327-337.
37. van der Meer A., Lukassen H.G., van Cranenbroek B., Weiss E.H., Braat D.D., et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol. Hum. Reprod. 2007, 13:123-133.
38. van Nieuwenhoven A.L.V., Moes H., Heineman M.J., Santema J., Faas M.M. Cytokine production by monocytes, NK cells, and lymphocytes is different in preeclamptic patients as compared with normal pregnant women. Hypertens. Pregnancy 2008, 27:207-224.
39. Vinnars M.-T., Wijnaendts L.C.D., Westgren M., Bolte A.C., Papadogiannakis N., et al. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension 2008, 51:1295-1299.
40. Widmer M., Villar J., Benigni A., Conde-Agudelo A., Karumanchi S.A., et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obst. Gynecol. 2007, 109:168-180.
41. Xin X., Higai K., Imaizumi Y., Suzuki C., Ito K., et al. Natural killer group 2A (NKG2A) and natural killer group 2C (NKG2C) bind to sulfated glycans and α2,3-NeuAc-containing glycoproteins. Biol. Pharmaceut. Bull. 2011, 34:480-485.
42. Zhang Z., Gong F., Jia L., Chang C., Hou L., et al. Studies on activity of NK cells in preeclampsia patients. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2004, 24:473-475.